DRGEM, Q1 2020, Sales Results (Provisional)

On 10th April, DRGEM Corporation, the Korean originated manufacturer of x-ray imaging systems, published provisional financial results for its first quarter of 2020. This includes high-level sales revenue and earnings based on K-IFRS. These are pre-audit values, therefore, these values may change and there may be differences with the results displayed within the quarterly business report. This earnings statement shows that the company achieved explosive sales growth during the first quarter. The overall company sales revenue reached KRW(₩)20.8 billion during Q1 2020, compared with KRW(₩)11.7 billion during Q1 2019, an increase of approximately 78% year-on-year.

Download DRGEM Investor Disclosure, Q1 2020 Results

Was this article of value to you?

Subscribe to the blog:

Subscribe to OEM Sales Results

By subscribing you are agreeing to receive financial and commercial reports on global medical imaging equipment OEMs via email. These reports are shared throughout the year as audited financial results become available. The current portfolio of medical imaging companies covered includes approximately 100 medical imaging OEMs. This email subscription service is free of charge and delivered by Stuart Kusta, Principal Analyst at Prerequisite Market Intelligence.

Processing…

Success! You're on the list.

Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.

Advertisement